The Regorafenib Tablets Market is gaining attention as the global oncology sector continues to focus on effective targeted therapies for patients with advanced and difficult-to-treat cancers. Regorafenib is an oral targeted therapy used in oncology treatment, and rising demand for personalized cancer care is supporting continued interest in this therapeutic segment. According to the referenced...